Resveratrol protects against chronic alcohol-induced liver disease in a rat model
Abstract
Hepatic ethanol metabolism participates in the pathogenesis of alcoholic liver disease (ALD). We aimed to evaluate the protecting effects and underlying mechanisms of Resveratrol against ALD. Adult male rats were fed with liquid ethanol diet, in the presence or absence of Resveratrol for 23 weeks. It was demonstrated that Resveratrol attenuated ethanol-induced release of serum alanine and aspartate aminotransferase. Ethanol insult caused malondialdehyde elevation and the impairment of antioxidant defense system, leading to reactive oxygen species generation, which could be greatly reversed by Resveratrol treatment. Moreover, Resveratrol protected against chronic ethanol-induced upregulation in hepatic cytochrome P-4502E1 expression, whereas hepatic alcohol dehydrogenase expression was unaffected by Resveratrol. Unexpectedly, hepatic aldehyde dehydrogenase2 expression was markedly diminished in ethanol-fed rats, which was gradually improved by Resveratrol treatment. Our data demonstrate that the protecting effects of Resveratrol on ALD might be associated with changes in the regulation of alcohol-metabolizing enzymes. Our findings could provide new perspective into the pharmacological targets of Resveratrol in the treatment of ALD.
Downloads
References
Tsukamoto H. Conceptual importance of identifying alcoholic liver disease as a lifestyle disease. J Gastroenterol 2007; 42(8): 603–9. doi: 10.1007/s00535-007-2075-3
Breitkopf K, Nagy LE, Beier JI, Mueller S, Weng H, Dooley S. Current experimental perspectives on the clinical progression of alcoholic liver disease. Alcohol Clin Exp Res 2009; 33(10): 1647–55. doi: 10.1111/j.1530-0277.2009.01015.x
Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004; 34(1): 9–19. doi: 10.1016/j.alcohol.2004.07.008
Mello T, Ceni E, Surrenti C, Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects Med 2008; 29(1–2): 17–21. doi: 10.1016/j.mam.2007.10.001
Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med 2008; 29(1–2): 9–16. doi: 10.1016/j.mam.2007.09.004
Setshedi M, Wands JR, Monte SM. Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev 2010; 3(3): 178–85. doi: 10.4161/oxim.3.3.12288
Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006; 5(6): 493–506. doi: 10.1038/nrd2060
Zern TL, West KL, Fernandez ML. Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J Nutr 2003; 133(7): 2268–72. doi: 10.1093/jn/133.7.2268
Ahn J, Cho I, Kim S, Kwon D, Ha T. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J Hepatol 2008; 49(6): 1019–28. doi: 10.1016/j.jhep.2008.08.012
Santos JA, de Carvaho GS, Oliveira V, Raposo NR, da Silva AD. Resveratrol and analogues: a review of antioxidant activity and applications to human health. Recent Pat Food Nutr Agric 2013; 5(2): 144–53. doi: 10.2174/18761429113059990001
Kasdallah-Grissa A, Mornagui B, Aouani E, Hammami M, El May M, Gharbi N, et al. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci 2007; 80(11): 1033–9. doi: 10.1016/j.lfs.2006.11.044
Kasdallah-Grissa A, Mornagui B, Aouani E, Hammami M, Gharbi N, Kamoun A, et al. Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats. Alcohol Alcohol 2006; 41(3): 236–9. doi: 10.1093/alcalc/agh256
Ajmo JM, Liang X, Rogers CQ, Pennock B, You M. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2008;295(4):G833–42. doi: 10.1152/ajpgi.90358.2008
You M, Liang X, Ajmo JM, Ness GC. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol 2008; 294(4): G892–8. doi: 10.1152/ajpgi.00575.2007
Ji C, Chan C, Kaplowitz N. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J Hepatol 2006; 45(5): 717–24. doi: 10.1016/j.jhep.2006.05.009
Yan Y, Yang JY, Mou YH, Wang LH, Zhou YN, Wu CF. Differences in the activities of resveratrol and ascorbic acid in protection of ethanol-induced oxidative DNA damage in human peripheral lymphocytes. Food Chem Toxicol 2012; 50(2): 168–74. doi: 10.1016/j.fct.2011.10.046
Piver B, Berthou F, Dreano Y, Lucas D. Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol Lett 2001; 125(1–3): 83–91. doi: 10.1016/S0378-4274(01)00418-0
Piver B, Berthou F, Dreano Y, Lucas D. Differential inhibition of human cytochrome P450 enzymes by epsilon-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages. Life Sci 2003; 73(9): 1199–213. doi: 10.1016/S0024-3205(03)00420-X
Tang Y, Xu J, Qu W, Peng X, Xin P, Yang X, et al. Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms. J Nutr Biochem 2012; 23(11): 1410–16. doi: 10.1016/j.jnutbio.2011.08.008
Zhao LN, Hao LP, Yang XF, Ying CJ, Yu D, Sun XF. The diabetogenic effects of excessive ethanol: reducing beta-cell mass, decreasing phosphatidylinositol 3-kinase activity and GLUT-4 expression in rats. Br J Nutr 2009; 101(10): 1467–73. doi: 10.1017/S0007114508094646
Rong S, Zhao Y, Bao W, Xiao X, Wang D, Nussler AK, et al. Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity. Phytomedicine 2012; 19(6): 545–50. doi: 10.1016/j.phymed.2011.12.006
Lieber CS, DeCarli LM. Animal models of chronic ethanol toxicity. Methods Enzymol 1994; 233: 585–94. doi: 10.1016/S0076-6879(94)33061-1
Bruha R, Dvorak K, Petrtyl J. Alcoholic liver disease. World J Hepatol 2012; 4(3): 81–90. doi: 10.4254/wjh.v4.i3.81
Comporti M, Signorini C, Leoncini S, Gardi C, Ciccoli L, Giardini A, et al. Ethanol-induced oxidative stress: basic knowledge. Genes Nutr 2010; 5(2): 101–9. doi: 10.1007/s12263-009-0159-9
Zakhari S, Li TK. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology 2007; 46(6): 2032–9. doi: 10.1002/hep.22010
Butura A, Nilsson K, Morgan K, Morgan TR, French SW, Johansson I, et al. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J Hepatol 2009; 50(3): 572–83. doi: 10.1016/j.jhep.2008.10.020
Albano E, Clot P, Morimoto M, Tomasi A, Ingelman-Sundberg M, French SW. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 1996; 23(1): 155–63. doi: 10.1002/hep.510230121
Lee JS. Supplementation of Pueraria radix water extract on changes of antioxidant enzymes and lipid profile in ethanol-treated rats. Clin Chim Acta 2004; 347(1–2): 121–8. doi: 10.1016/j.cccn.2004.04.002
Cederbaum AI. Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity. Dig Dis 2010; 28(6): 802–11. doi: 10.1159/000324289
Clemens DL. Effects of ethanol on hepatic cellular replication and cell cycle progression. World J Gastroenterol 2007; 13(37): 4955–9. doi: 10.3748/wjg.v13.i37.4955
Latvala J, Hietala J, Koivisto H, Jarvi K, Anttila P, Niemela O. Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. Am J Gastroenterol 2005; 100(6): 1303–10. doi: 10.1111/j.1572-0241.2005.41509.x
Lluis JM, Colell A, Garcia-Ruiz C, Kaplowitz N, Fernandez-Checa JC. Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology 2003; 124(3): 708–24. doi: 10.1053/gast.2003.50089
You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 2002; 277(32): 29342–7. doi: 10.1074/jbc.M202411200
Shen Z, Ajmo JM, Rogers CQ, Liang X, Le L, Murr MM, et al. Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol 2009; 296(5): G1047–53. doi: 10.1152/ajpgi.00016.2009
Guo R, Zhong L, Ren J. Overexpression of aldehyde dehydrogenase-2 attenuates chronic alcohol exposure-induced apoptosis, change in Akt and Pim signalling in liver. Clin Exp Pharmacol Physiol 2009; 36(5–6): 463–8. doi: 10.1111/j.1440-1681.2009.05152.x
Lu Y, Wu D, Wang X, Ward SC, Cederbaum AI. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radic Biol Med 2010; 49(9): 1406–16. doi: 10.1016/j.freeradbiomed.2010.07.026
Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 2008; 44(5): 723–38. doi: 10.1016/j.freeradbiomed.2007.11.004
Lu Y, Zhuge J, Wang X, Bai J, Cederbaum AI. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 2008; 47(5): 1483–94. doi: 10.1002/hep.22222
Ramaiah SK. A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters. Food Chem Toxicol 2007; 45(9): 1551–7. doi: 10.1016/j.fct.2007.06.007
Xin P, Han H, Gao D, Cui W, Yang X, Ying C, et al. Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats. Food Chem Toxicol 2013; 52: 12–18. doi: 10.1016/j.fct.2012.10.026
Cederbaum AI, Lu Y, Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 2009; 83(6): 519–48. doi: 10.1007/s00204-009-0432-0
Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med 2008; 44(7): 1259–72. doi: 10.1016/j.freeradbiomed.2007.12.029
French SW. The importance of CYP2E1 in the pathogenesis of alcoholic liver disease and drug toxicity and the role of the proteasome. Subcell Biochem 2013; 67: 145–64. doi: 10.1007/978-94-007-5881-0_4
Copyright (c) 2022 Hanzhang Zhu, Jun Lu, Weijiang Zhou, Changku Jia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain full copyright to their individual works, and publishing rights without restrictions.
In accordance with the Budapest Open Access Initiative, articles published in STEMedicine are freely available "on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited."
Except where otherwise noted, all content on this website is licensed under a Creative Commons Attribution 4.0 License. This license allows for commercial and non-commercial redistribution as well as modifications of the work as long as attribution is given to the authors and STEMedicine as the original publication source, and a link to the article on the STEMedicine website is provided.
